Related Experiment Video
Updated: Mar 13, 2026
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Efficacy of palliative radiation therapy for symptomatic rectal cancer
David Chia1, Jiade Lu1, HuiLi Zheng2
1Department of Radiation Oncology, National University Hospital, National Cancer Institute of Singapore, Singapore; Department of Radiation Oncology, Tan Tock Seng Hospital, National Cancer Institute of Singapore, Singapore.
Abstract:
99 patients with symptomatic locally advanced rectal cancer who were treated with palliative radiation alone were reviewed. Dose-fractionation ranged from 18 to 54Gy. Response rate ranged from 62.5 to 86.7%, with a median response duration ranging 4.2-5.4months. Median survival was 6.9months. Using a BED cut-off of 39Gy10, no dose-response relationship was found.
